IP Library Granted Patent US 8,420,774
Granted Patent B2
US 8,420,774 · App. 12/628,666 · Granted Apr 16, 2013

Decorating hydroxyapatite biomaterials with modular biologically active molecules

Inventors: William L. Murphy (Madison, WI); Jae Sung Lee (Madison, WI); Mark D. Markel (Middleton, WI); Ben K. Graf (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,774
App. No.
12/628,666
Granted
Apr 16, 2013
Kind
B2
Abstract

A modular peptide design strategy wherein the modular peptide has two functional units separated by a spacer portion is disclosed. More particularly, the design strategy combines a hydroxyapatite-binding portion and a biomolecule-derived portion. The modular peptides have improved non-covalent binding to the surface of the HA-based materials, and are capable of initiating osteogenesis, angiogenesis, and/or osteogenic differentiation.

Claims (7)

1. A modular peptide for non-covalently binding to a surface of a biomaterial, the modular peptide comprising: a hydroxyapatite-binding portion, a spacer portion, and a biomolecule-derived portion, wherein the hydroxyapatite-binding portion comprises an amino acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6.

2. The modular peptide as set forth in claim 1 wherein the biomaterial is selected from the group consisting of hydoxyapatite and hydroxyapatite-based materials.

3. The modular peptide as set forth in claim 1 wherein the spacer portion is an amino acid sequence capable of forming an α-helix.

4. The modular peptide as set forth in claim 1 wherein the spacer portion is SEQ ID NO:7.

5. The modular peptide as set forth in claim 1 wherein the biomolecule-derived portion is a growth factor capable of initiating at least one of osteogenesis, angiogenesis, and osteogenic differentiation.

6. The modular peptide as set forth in claim 5 wherein the growth factor comprises an amino acid sequence selected from the group consisting of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11.

7. The modular peptide as set forth in claim 1 having the sequence selected from the group consisting of SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO: 14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, and SEQ ID NO:18.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2010
From: MURPHY, WILLIAM; MARKEL, MARK; GRAF, BEN; LEE, JAE SUNG
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 024269/0910 →
Continuity (1)
Related Publication 20110129611A1 · Jun 2, 2011